Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Open-market buy Director bought 80,646 shares at $0.31 ($25,000)
  2. 4 Open-market buy COO, Secretary, Gen. Counsel bought 80,646 shares at $0.31 ($25,000)
  3. 4 Open-market buy CEO & President bought 161,291 shares at $0.31 ($50,000)
  4. 4 Insider Changes in Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award CEO & President acquired 32,895 shares (grant or award)
  10. 4 Grant or award Director acquired 24,500 shares (grant or award)
  11. 4 Grant or award COO, Secretary, Gen. Counsel acquired 4,902 shares (grant or award)
  12. 4 Grant or award CEO & President acquired 49,020 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4/A Grant or award CEO & President acquired 21,552 shares (grant or award)
  20. 4 Grant or award CEO, President acquired 21,552 shares (grant or award)

Page 5 of 31 · 614 filings